Mouridsen, H T <br/><br/>
Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group.  [electronic resource] 

 -  European journal of cancer & clinical oncology  Oct 1987 
 - 1477-83 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0277-5379 
<br/><br/><label>Standard No.: </label>10.1016/0277-5379(87)90089-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Doxorubicin--adverse effects<br/>Drug Evaluation<br/>Epirubicin<br/>Female<br/>Hematologic Diseases--chemically induced<br/>Humans<br/>Male<br/>Middle Aged<br/>Random Allocation<br/>Sarcoma--drug therapy<br/>Soft Tissue Neoplasms--drug therapy<br/>Time Factors